Published in Physician Law Weekly, January 24th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Johnson & Johnson.
Report 1: Johnson & Johnson (JNJ) and Conor Medsystems, Inc., (CONR), a cardiovascular device company, announced a definitive agreement whereby Johnson & Johnson will acquire Conor Medsystems for approximately $1.4 billion.
The acquisition of Conor Medsystems by Johnson & Johnson will provide Cordis Corp., a Johnson & Johnson company, with a unique controlled drug-delivery technology. This technology is currently employed on the CoStar Stent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.